Medical University of Vienna
🇦🇹Austria
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1365-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.meduniwien.ac.at
Perioperative Heart Rate Variability Analysis in Realtime
Completed
- Conditions
- Heart Rate and Rhythm DisordersSurgical Complications From General AnesthesiaPerioperative/Postoperative ComplicationsIndividuality
- First Posted Date
- 2016-05-04
- Last Posted Date
- 2018-08-20
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 88
- Registration Number
- NCT02761031
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Wien, Austria
Enhancement of Learning Associated Neural Plasticity by Selective Serotonin Reuptake Inhibitors
Phase 4
- Conditions
- SsriNeuronal Plasticity
- Interventions
- Drug: PlaceboDrug: EscitalopramOther: 3xMR scan (fMRI, DTI, strucutral MRI)Behavioral: Association learning paradigmBehavioral: Association re-learning paradigm
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2016-04-28
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 80
- Registration Number
- NCT02753738
- Locations
- 🇦🇹
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Intensive Stress Coping Intervention Week - A Secondary Prevention For Real World Affective Disorder Patients
Not Applicable
Completed
- Conditions
- Psychological StressAnxiety DisordersMood DisordersInflammationAffective DisordersOxidative StressEmotions
- Interventions
- Behavioral: stress-coping weekBehavioral: additional two days follow-up weekend
- First Posted Date
- 2016-04-26
- Last Posted Date
- 2016-09-16
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 43
- Registration Number
- NCT02752295
Pharmacodynamic Effects of Riociguat in Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
Phase 2
Completed
- Conditions
- Hypertension, PulmonaryHeart Failure With Normal Ejection Fraction
- Interventions
- Drug: PlaceboDrug: Riociguat
- First Posted Date
- 2016-04-20
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 118
- Registration Number
- NCT02744339
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Resilience in Irritable Bowel Syndrome and Gut-focused Hypnotherapy
Not Applicable
Completed
- Conditions
- Irritable Bowel Syndrome
- Interventions
- Behavioral: Gut-directed Hypnotherapy
- First Posted Date
- 2016-04-13
- Last Posted Date
- 2016-04-13
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 74
- Registration Number
- NCT02737410
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Pembrolizumab Plus Docetaxel for the Treatment of Recurrent or Metastatic Head and Neck Cancer
- First Posted Date
- 2016-03-24
- Last Posted Date
- 2024-01-09
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 22
- Registration Number
- NCT02718820
- Locations
- 🇦🇹
Medical University of Vienna, Vienna, Austria
Positron Emission Tomography Assessment of Ketamine Binding of the Serotonin Transporter
Phase 2
- Conditions
- DepressionKetamine
- Interventions
- Drug: PlaceboDrug: (R,S)-ketamine (Pilot II)Drug: (R,S)-ketamine (Pilot I)Drug: (R,S)-ketamine (Pilot III)Drug: (S)-ketamine (Main study)Drug: (S)-ketamine (Pilot II)
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 74
- Registration Number
- NCT02717052
- Locations
- 🇦🇹
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
Effects of Sex Steroids on the Serotonin System
Phase 4
- Conditions
- Gender Dysphoria
- Interventions
- First Posted Date
- 2016-03-22
- Last Posted Date
- 2018-10-15
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 92
- Registration Number
- NCT02715232
- Locations
- 🇦🇹
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
High-resolution Imaging of Tear Film Thickness in Contact Lenses Wearers With Optical Coherence Tomography (OCT). A Pilot Study
- Conditions
- Tear Film ThicknessContact Lens
- Interventions
- Device: Optical Coherence Tomography
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2022-04-07
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 30
- Registration Number
- NCT02713399
- Locations
- 🇦🇹
Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria
Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)
Phase 4
- Conditions
- Major Depressive Disorder
- First Posted Date
- 2016-03-17
- Last Posted Date
- 2019-09-03
- Lead Sponsor
- Medical University of Vienna
- Target Recruit Count
- 80
- Registration Number
- NCT02711215
- Locations
- 🇦🇹
Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria
© Copyright 2025. All Rights Reserved by MedPath